Inhibikase Therapeutics, Inc. - Common Stock (IKT)

2.0550
+0.0350 (1.73%)
NASDAQ · Last Trade: Sep 30th, 5:03 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors